Priority MedXpress
Priority MedXpress
  • Home
  • Company
    • Who We Are
    • Our Services
    • Our Edge
    • Policies
    • FAQ
  • Resources
    • DOT - Policy & Compliance
    • SAMHSA
    • Counseling & Support
  • More
    • Home
    • Company
      • Who We Are
      • Our Services
      • Our Edge
      • Policies
      • FAQ
    • Resources
      • DOT - Policy & Compliance
      • SAMHSA
      • Counseling & Support
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Company
    • Who We Are
    • Our Services
    • Our Edge
    • Policies
    • FAQ
  • Resources
    • DOT - Policy & Compliance
    • SAMHSA
    • Counseling & Support

Account

  • Bookings
  • My Account
  • Sign out

  • Sign In
  • Bookings
  • My Account

Frequently Asked Questions

Please reach us at info@prioritymedxpress.com if you cannot find an answer to your question.

At Priority MedXpress, we are committed to providing a safe, professional, and comfortable environment for all testing services. Our staff is trained to ensure that every collection process is conducted with efficiency, discretion, and full respect for client privacy.


  To ensure a smooth and timely testing experience, please bring the following items:

  • CCF Test Request Form provided by your healthcare professional, employer, or requesting agency
  • Current insurance identification card (Medicare, private insurance, or HMO/PPO)
  • Valid photo identification (e.g., driver’s license, passport, or employee ID badge)
  • Payment method such as a health spending account card, credit card, or debit card


  • Children must be supervised at all times.
  • For safety and compliance reasons, children are not permitted inside the collection area during drug screen procedures. Please arrange childcare in advance of your appointment.


In accordance with U.S. Department of Transportation (DOT) regulations (49 CFR Part 40), the following protocol applies if a donor is unable to provide the required urine specimen during a drug test:

  1. Initial Attempt: If the donor cannot provide a sufficient specimen, they will be instructed to remain at the collection site.

** You CANNOT leave the location and will be under observation for the remainder of the time you are with the collector. **

  1. Hydration Period: The donor may be given up to 40 ounces of fluid (distributed reasonably over time) and up to three hours to attempt to provide a specimen.
  2. Multiple      Attempts: The donor may make several attempts within the      three-hour window.
  3. Failure to Provide: If the donor is still unable to provide a specimen      after three hours, the situation will be documented as a “shy bladder”. The Medical Review Officer (MRO) will then determine whether there is a valid medical explanation.
  4. Medical Evaluation: The donor may be referred for a medical evaluation to      rule out any underlying conditions that could explain the inability to provide a specimen.

This process ensures fairness, regulatory compliance, and the integrity of the testing program.


Split specimen collection is a method used in drug testing—especially in Department of Transportation (DOT) regulated environments—where a single urine sample is split into two separate containers at the time of collection:

• Primary Specimen: Sent to a certified lab for initial drug testing.

• Split Specimen: Stored securely for potential retesting.

Why It’s Done

This process ensures fairness and accuracy in drug testing. If the primary sample tests positive, the donor (employee or individual being tested) has the right to request that the split specimen be tested at a different certified lab to confirm or refute the result.

• Employee Protection: Guards against false positives due to lab errors, contamination, or medication interactions.

• Employer Integrity: Prevents tampering, since the retest uses the original sample—not a new one.

Retest Timeline & Rights

• The Medical Review Officer (MRO) notifies the donor of a positive result.

• The donor has 72 hours to request a retest of the split specimen.

• If the second test does not confirm the initial result, the outcome is reported as negative.

Who Pays for Retesting?

• Payment responsibility depends on the employer’s drug-free workplace policy.

• If the policy doesn’t specify, the employer typically covers the cost.


  • Home
  • Privacy Policy

Priority MedXpress

919.200.6162

Copyright © 2026 Priority MedXpress - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept